This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Sector ETFs to Win & Lose on Oil Price Rebound
by Sanghamitra Saha
This has been a tough year for the oil sector with prices tumbling in the first half of the year and gaining in the latter half of the year.
Should You Buy Oil & Gas ETFs Now?
by Neena Mishra
Energy ETFs rebounded strongly in November but are still down significantly for the year
MLP ETFs Riding High: Can the Rally Sustain?
by Sanghamitra Saha
It seems that the coronavirus blues of the energy sector are slowly passing away. Vaccine and stimulus hopes as well as prudent cash management have helped the MLP space winner in recent weeks.
Is it a Good Idea to Invest in Oil ETFs? Let's Find Out
by Sweta Jaiswal, FRM
Here we discuss whether it will be prudent to pick oil ETFs now as the oil market strengthens on rising demand amid progress in coronavirus vaccine development.
4 Inverse leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street crashed last week on renewed virus fear, election uncertainty and subdued tech earnings.
Top & Flop ETF Zones of First Nine Months of 2020
by Sweta Killa
We have highlighted the best and worst-performing zones and their ETFs in the first nine months of 2020.
Beat Election Fears With 6 ETFs as Markets May Soar in 2021
by Sanghamitra Saha
All eyes are on the U.S. presidential debate. But Wall Street is likely to stay steady in 2021 irrespective of who wins the election as solid job gains appear to be on the way.
Tropical Storms Put These Oil ETFs in Focus
by Sweta Killa
Oil price has shown some strength over the past couple of days as the two tropical storms - Marco and Laura - threatened more than half of the production in the Gulf of Mexico and prompted refinery cuts.
Sector ETFs to Win or Lose on Storm-Led Oil Price Jump
by Sanghamitra Saha
As oil prices jumped, these sector ETFs may gain or lose.
S&P 500 Near Record Close: 3 Winning Sectors & ETFs
by Sanghamitra Saha
S&P 500 got charged up on Aug 12 on vaccine and further stimulus hopes as well as better-than-feared second-quarter earnings.